Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian MacLachlan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Nature Biotechnology|April 9, 2008
siRNAs with gutsIan Maclachlan
Human Gene Therapy|January 31, 2008
Overcoming the innate immune response to small interfering RNAAdam Judge, Ian MacLachlan
Advances in Genetics|October 26, 2005
"Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles"Ian Maclachlan, Pieter Cullis
Advances in Genetics|October 26, 2005
"Diffusible-PEG-lipid stabilized plasmid lipid particles"Ian MacLachlan, Pieter Cullis
Oligonucleotides|May 16, 2009
siRNA and innate immunityMarjorie Robbins, Adam Judge, Ian MacLachlan
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2005
Factors limiting autogene-based cytoplasmic expression systemsJonathan Finn, Ian MacLachlan, Pieter Cullis
Methods in Enzymology|March 9, 2002
Stabilized plasmid-lipid particles: a systemic gene therapy vectorDavid B Fenske, Ian MacLachlan, Pieter R Cullis
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 2, 2005
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJames Heyes, Lorne Palmer, Kaz Bremner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 9, 2005
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomesAdam Judge, Kevin McClintock, Janet R Phelps, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2006
Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug deliveryJames Heyes, Kim Hall, Vicky Tailor, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Nature Biotechnology|April 9, 2008
siRNAs with gutsIan Maclachlan
Human Gene Therapy|January 31, 2008
Overcoming the innate immune response to small interfering RNAAdam Judge, Ian MacLachlan
Advances in Genetics|October 26, 2005
"Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles"Ian Maclachlan, Pieter Cullis
Advances in Genetics|October 26, 2005
"Diffusible-PEG-lipid stabilized plasmid lipid particles"Ian MacLachlan, Pieter Cullis
Oligonucleotides|May 16, 2009
siRNA and innate immunityMarjorie Robbins, Adam Judge, Ian MacLachlan
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2005
Factors limiting autogene-based cytoplasmic expression systemsJonathan Finn, Ian MacLachlan, Pieter Cullis
Methods in Enzymology|March 9, 2002
Stabilized plasmid-lipid particles: a systemic gene therapy vectorDavid B Fenske, Ian MacLachlan, Pieter R Cullis
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 2, 2005
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJames Heyes, Lorne Palmer, Kaz Bremner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 9, 2005
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomesAdam Judge, Kevin McClintock, Janet R Phelps, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2006
Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug deliveryJames Heyes, Kim Hall, Vicky Tailor, et al.
Pageof 4